A carregar...

Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV – focus on pegylated interferon-alpha

In immuno-competent individuals, the natural course of chronic hepatitis C virus (HCV) infection is highly variable and 5%–30% of patients develop cirrhosis over 20 years. Co-infection with HCV and human immunodeficiency virus (HIV) is an important prognostic factor and associated with more frequent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zoller, Heinz, Vogel, Wolfgang
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2006
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2676642/
https://ncbi.nlm.nih.gov/pubmed/17722274
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!